Target intelligence / Profile preview

BFSP2 antisense RNA 1 (BFSP2-AS1)

Target: BFSP2-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

BFSP2 antisense RNA 1 (BFSP2-AS1) is a human gene encoding a long non-coding RNA transcript located on chromosome 3 (hg38 coordinates: chr3:133426402-133491163). The gene is transcribed in the antisense orientation relative to the protein-coding BFSP2 gene, which encodes beaded filament structural protein 2 (phakinin), a structural constituent of the lens. The exact regulatory or biological functions of BFSP2-AS1 are currently poorly understood, and there is no established role in disease, therapeutic targeting, or clinical biomarkers. If a more detailed experimental or clinical validation emerges, these entries may warrant updating, but based on present evidence, BFSP2-AS1 is best classified as a long non-coding RNA locus without known therapeutic or biomarker significance.

Other names: MGC2848BFSP2-AS1

Mechanism of action

Not applicable; there are no drugs identified that target BFSP2-AS1

Biological functions

Potential regulatory function at the RNA level; possible involvement in modulating transcription and gene expression of the adjacent BFSP2 gene or other elements, but specific precise functions are not yet experimentally established

Disease associations

None definitively established. No reported, experimentally validated link to any disease in the available sources. Some long non-coding RNAs are involved in cancer or immune regulation, but no direct evidence for BFSP2-AS1 is reported.

Safety considerations

None recognized; it is not a therapeutic target and is not associated with safety concerns in clinical development

Beyond the preview

Go deeper on BFSP2 antisense RNA 1 (BFSP2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BFSP2 antisense RNA 1 (BFSP2-AS1).

Explore the full profile